Literature DB >> 11901040

Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling.

Leslie A Saxon1, Teresa De Marco, Jill Schafer, Kanu Chatterjee, Uday N Kumar, Elyse Foster.   

Abstract

BACKGROUND: Long-term ventricular resynchronization therapy improves symptom status. Changes in left ventricular remodeling have not been adequately evaluated. METHODS AND
RESULTS: Fifty-three patients with systolic heart failure and bundle-branch block underwent implantation of biventricular stimulation (BVS) devices as part of a randomized trial. Echocardiograms were acquired at randomization and at 6-week intervals until completion of 12 weeks of continuous BVS. There were no changes in heart rate or QRS duration after 12 weeks of BVS. Serum norepinephrine values did not change with BVS. After 12 weeks of BVS, left atrial volume decreased. Left ventricular end-systolic and end-diastolic dimensions and left ventricular end-systolic volume also decreased after 12 weeks of BVS. Sphericity index did not change. Measures of systolic function, including left ventricular outflow tract and aortic velocity time integral and myocardial performance index, improved.
CONCLUSIONS: Long-term resynchronization therapy results in atrial and ventricular reverse remodeling and improved hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901040     DOI: 10.1161/hc1102.105730

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

1.  Real-time stroke volume measurements for the optimization of cardiac resynchronization therapy parameters.

Authors:  José M Dizon; T Alexander Quinn; Santos E Cabreriza; Daniel Wang; Henry M Spotnitz; Kathleen Hickey; Hasan Garan
Journal:  Europace       Date:  2010-06-04       Impact factor: 5.214

2.  Left ventricular shape index assessed by gated stress myocardial perfusion SPECT: initial description of a new variable.

Authors:  Aiden Abidov; Piotr J Slomka; Hidetaka Nishina; Sean W Hayes; Xingping Kang; Shunichi Yoda; Ling-De Yang; James Gerlach; Fatma Aboul-Enein; Ishac Cohen; John D Friedman; Paul B Kavanagh; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

Review 3.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 4.  Cardiac resynchronisation therapy: when the drugs don't work.

Authors:  R A Bleasdale; M P Frenneaux
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

5.  [Cardiac resynchronization therapy--what will the future bring?].

Authors:  C Stellbrink
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2005-03

6.  [Optimized CRT programming: relevance and practical application].

Authors:  F Bode; F Schütte
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

7.  QRS duration in the selection of patients for cardiac resynchronization therapy.

Authors:  Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

Review 8.  Cardiac resynchronization therapy.

Authors:  Silke Isabelle Trautmann; Michael Kloss; Angelo Auricchio
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

9.  Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study.

Authors:  Gregory W Woo; Susan Petersen-Stejskal; James W Johnson; Jamie B Conti; Juan A Aranda; Anne B Curtis
Journal:  J Interv Card Electrophysiol       Date:  2005-03       Impact factor: 1.900

10.  Cardiac Resynchronization Therapy for Advanced Heart Failure.

Authors:  Philip B. Adamson; William T. Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.